Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | GLP1R | P43220 | 9/20 | 0.58 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.57 |
| ▸ | CALCR | P30988 | 3/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | CCKBR | P32239 | 1/20 | 0.55 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.55 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30435350 | 0.89 | GLP1R (0.62) | KEAP1GLP1RCALCRCCKBRCRHR1 | |
| SCHEMBL30658293 | 0.88 | CALCR (0.65) | KEAP1GLP1RPTH1RCALCRRXFP1 | |
| SCHEMBL29520076 | 0.88 | GLP1R (0.67) | KEAP1GLP1RPTH1RCALCRCCKBR | |
| SCHEMBL30176460 | 0.88 | GLP1R (0.57) | KEAP1GLP1R | |
| SCHEMBL30658288 | 0.88 | GLP1R (0.64) | KEAP1GLP1RPTH1RCALCRRXFP1 | |
| SCHEMBL30979202 | 0.87 | GLP1R (0.64) | KEAP1GLP1RPTH1RCALCRCCKBR | |
| SCHEMBL30529017 | 0.87 | PTH1R (0.65) | KEAP1GLP1RPTH1RCALCRRXFP1 | |
| SCHEMBL30432587 | 0.87 | GLP1R (0.66) | GLP1R | |
| SCHEMBL29586748 | 0.87 | KEAP1 (0.66) | KEAP1GLP1RPTH1RCALCRRXFP1 | |
| SCHEMBL30387584 | 0.86 | GLP1R (0.65) | KEAP1GLP1RPTH1RCALCRCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |